Coccidioidomycosis

Infectious Disease Clinics of North America

Volumn 17, Issue 1, 2003, Pages 41-57

  Chiller, Tom M ^a,b   Galgiani, John N ^c,d   Stevens, David A ^a,b  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d 2 112 Tucson   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; GAMMA INTERFERON; INTERLEUKIN 12; ITRACONAZOLE; NIKKOMYCIN Z; POSACONAZOLE;

BACKACHE; CLINICAL FEATURE; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; FEVER; HEADACHE; HOST RESISTANCE; HUMAN; NERVE PARALYSIS; NEUROPATHY; NEUROTOXICITY; PARESTHESIA; PATHOGENESIS; PREVALENCE; REVIEW; SIDE EFFECT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BONE DISEASES; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; FEMALE; HUMANS; LUNG DISEASES, FUNGAL; MENINGITIS, FUNGAL; PREVALENCE; RISK; SKIN DISEASES; VACCINES;

EID: 0345700333     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(02)00040-5     Document Type: Review

References (44)

1. Posada A. Un Nuevo caso de micosis fungoidea con psorospermias. An Circ Med Argent 1892;15:585-97.
2. Rixford E, Gilchrist T. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep 1896;1:209-68.
3. Ophüls W, Moffitt H. A new pathogenic mould (formerly described as a protozoan (Coccidioides immitis pyogenes): preliminary report. Philadelphia Med 1900;J5:1471-2.
4. Dickson E. Valley fever" of the San Joaquin Valley and fungus Coccidioides. Calif West Med 1937;47:151-5.
5. Smith C, Beard R, Whiting E. Varieties of coccidioidal infection in relation to the epidemiology and control of the disease. Am J Public Health 1946;36:1394-402.
6. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol 1988;2: 199-238.
7. Werner SB, Pappagianis D, Heindl I, et al. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med 1972;286:507-12.
8. Larwood TR. Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin Infect Dis 2000;30:612-3.
9. Dodge RR, Lebowitz MD, Barbee RA, et al. Estimates of C immitis infection by skin test reactivity in an endemic community. Am J Public Health 1985;75:863-5.
10. Peterson CM, Schuppert K, Kelly PC, et al. Coccidioidomycosis and pregnancy. Obstet Gynecol Surv 1993;48:149-56.
11. Wack EE, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during pregnancy: an analysis of ten cases among 47,120 pregnancies. Chest 1988;94:376-9.
12. Gifford MA, Douds RJ, Miller HE, et al. Data on coccidioides fungus infection, Kern County, Bakersfield, CA. Kern County Public Health Annual Report. Bakersfield (CA): Kern County; 1936. p. 39-54.
13. Centers for Disease Control (CDC). Coccidioidomycosis - United States 1991-1992. MMWR Morb Mortal Wkly Rep 1993;42:21-4.
14. Einstein HE, Johnson RH. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis 1993;16:349-54.
15. Hagman HM, Madnick EG, D'Agostina AN, et al. Hyphal forms in the central nervous system of patients with coccidioidomycosis. Clin Infect Dis 2000;30:349-55.
16. Kong Y, Levine H, Madin S, et al. Fungal multiplication and histopathologic changes in vaccinated mice infected with Coccidioides immitis. J Immunol 1964;92:779-90.
17. Savage DC, Madin SH. Cellular responses in lungs of immunized mice to intranasal infection with Coccidioides immitis. Sabouraudia 1968;6:94-102.
18. Galgiani JN, Isenberg RA, Stevens DA. Chemotaxigenic activity of extracts from the mycelial and spherule phases of Coccidioides immitis for human polymorphonuclear leukocytes. Infect Immun 1978;21:862-5.
19. Magee D, Cox R. Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect Immun 1995;63:3514-9.
20. Resnick S, Pappagianis D, McKerrow J. Proteinase production by the parasitic cycle of the pathogenic fungus Coccidioides immitis. Infect Immun 1987;55:2807-15.
21. Read CT. Coin lesion, pulmonary: in the Southwest (solitary pulmonary nodules). Ariz Med 1972;29:775-81.
22. Forseth J, Rohwedder J, Levine B, et al. Experience with needle biopsy for coccidioidal lung nodules. Arch Intern Med 1986;146:319-20.
23. Petersen E, Friedman B, Crowder E, et al. Coccidoidouria: clinical significance. Ann Intern Med 1976;85:34-8.
24. Jacobs P. Cutaneous coccidioidomycosis. In: Stevens DA, editor. Coccidioidomycosis: a text. New York: Plenum Publishing; 1980. p. 213-24.
25. Deresinski SC. Coccidioidomycosis of the bone and joint. In: Stevens DA, editor. Coccidioidomycosis: a text. New York: Plenum Publishing; 1980. p. 195-211.
26. Banuelos AF, Williams PL, Johnson RH, et al. Central nervous system abscesses due to Coccidioides species. Clin Infect Dis 1996;22:240-50.
27. Stevens DA. Coccidioidomycosis. N Engl J Med 1995;332:1077-82.
28. Galgiani J. Coccidioidomycosis. West J Med 1993;159:153-71.
29. Stockman L, Clark KA, Hunt JM, et al. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol 1993;31:845-50.
30. Galgiani JN, Grace GM, Lundergan LL. New serologic tests for early detection of coccidioidomycosis. J Infect Dis 1991;163:671-4.
31. Beard JS, Benson PM, Skillman L. Rapid diagnosis of coccidioidomycosis with a DNA probe to ribosomal RNA. Arch Dermatol 1993;129:1589-93.
32. Galgiani JN, Ampel NM, Catanzaro A, et al. Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:658-61.
33. Clemons KV, Stevens DA. Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis. Antimicrob Agents Chemother 1991;35:1829-33.
34. Clemons KV, Stevens DA. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis. J Antimicrob Chemother 1992;30:353-63.
35. Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. Am J Med 1995;98:249-56.
36. Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis: a randomized, double-blind trial. Ann Intern Med 2000;133:676-86.
37. Tucker RM, Denning DW, Arathoon EG, et al. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. J Am Acad Dermatol 1990;23: 593-601.
38. Diaz M, Negroni R, Montero-Gei F, et al. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Clin Infect Dis 1992;14(suppl 1): S68-76.
39. Einstein HE. Coccidioidal meningitis: the use of amphotericin B in treatment. Calif Med 1961;94:339-43.
40. Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med 1996;124:305-10.
41. Clemons KV, Sobel RA, Williams PL, et al. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrob Agents Chemother 2002;46:2420-6.
42. Jiang C, Magee DM, Cox RA. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis. Infect Immun 1999;67:5848-53.
43. Lutz JE, Clemons KV, Aristizabal BH, et al. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis. Antimicrob Agents Chemother 1997;41:1558-61.
44. Pappagianis D, Valley Fever Vaccine Study Group. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am Rev Respir Dis 1993;148: 656-60.